Case Report
Copyright ©The Author(s) 2021.
World J Hepatol. Mar 27, 2021; 13(3): 384-392
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.384
Table 1 Case reports of conversion hepatectomy after lenvatinib treatment
Ref.
Age/sex
Background disease
Regimen
Reason for unresectivity
Former treatment
Child-Pugh classification
Duration
RDI (%)
Type of hepatectomy
Prognosis
Sato et al[23] (2019)66/FHCVLenvatinibLarge sizeTACE8 (B)6 mo70Extended right hepatectomy3 mo alive with no recurrence
Chen et al[26] (2019)69/FHBVLenvatinib, nivolmabLarge sizeSorafenib TACE8 (B)3.5 mo100Extended right hepatectomy3 mo alive with no recurrence
Takahashi et al[25] (2019)82/FNon B/CLenvatinibLung metastasisNone5 (A)13 mo38Extended posterior segmentectomy5 mo alive with no recurrence
Present study59/MHCVLenvatinibPVTT (Vp4)None5 (A)3 mo100Left hepatectomy8 mo alive with no recurrence